These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37387314)

  • 1. CD123 and MxA expression in a case of annular erythema associated with primary Sjögren's syndrome successfully treated with hydroxychloroquine.
    Matsumura N; Yamamoto T
    Australas J Dermatol; 2023 Aug; 64(3):e280-e282. PubMed ID: 37387314
    [No Abstract]   [Full Text] [Related]  

  • 2. Annular erythema of Sjögren's syndrome.
    de Winter S; van Buchem MA; Vermeer MH
    Lancet; 2006 May; 367(9522):1604. PubMed ID: 16698414
    [No Abstract]   [Full Text] [Related]  

  • 3. Annular erythema: a possible association with primary Sjögren's syndrome.
    Teramoto N; Katayama I; Arai H; Eto H; Kamimura K; Uetsuka M; Kondo S; Nishioka K; Nishiyama S
    J Am Acad Dermatol; 1989 Apr; 20(4):596-601. PubMed ID: 2715407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of hydroxychloroquine for treating annular erythema associated with Sjögren's syndrome.
    Arakawa H; Tanese K; Tanaka R; Murakami K; Sujino K; Miyamoto J; Amagai M; Tanikawa A
    J Dermatol; 2021 Oct; 48(10):1526-1532. PubMed ID: 34254339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annular erythema, dermatomyositis, and Sjögren's syndrome.
    Watanabe T; Tsuchida T; Furue M; Yoshinoya S
    Int J Dermatol; 1996 Apr; 35(4):285-7. PubMed ID: 8786189
    [No Abstract]   [Full Text] [Related]  

  • 6. Annular erythematous plaques as manifestation of vasculitis in pediatric Sjögren's syndrome.
    Appelt LM; Lander F; Beissert S; Günther C
    Rheumatology (Oxford); 2022 Feb; 61(2):e43-e45. PubMed ID: 34599800
    [No Abstract]   [Full Text] [Related]  

  • 7. Type II cryoglobulinaemic vasculitis with primary Sjögren's syndrome successfully treated with belimumab and hydroxychloroquine.
    Izuka S; Yamashita H; Takahashi Y; Kaneko H
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):223-224. PubMed ID: 33666157
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-signal recognition particle antibody-positive polymyositis in a patient with Sjögren's syndrome showing various types of annular erythema: Positive correlation between the activities of annular erythema and myositis.
    Kabuto M; Fujimoto N; Hamaguchi Y; Tanaka T
    J Dermatol; 2016 Aug; 43(8):958-61. PubMed ID: 26972113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Annular Eruptions in a Patient with Sjögren's Syndrome: A Quiz.
    Kaisho J; Egawa G; Kaku Y; Kabashima K
    Acta Derm Venereol; 2020 Aug; 100(15):adv00227. PubMed ID: 32556360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urticated annular erythema: a new manifestation of Sjögren's syndrome.
    Ostlere LS; Harris D; Rustin MH
    Clin Exp Dermatol; 1993 Jan; 18(1):50-1. PubMed ID: 8440054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annular erythema associated with Sjögren's syndrome.
    Katayama I; Teramoto N; Arai H; Nishiyama S; Nishioka K
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):276. PubMed ID: 1430376
    [No Abstract]   [Full Text] [Related]  

  • 12. Annular erythema associated with Sjögren's syndrome: review of the literature on the management and clinical analysis of skin lesions.
    Katayama I; Kotobuki Y; Kiyohara E; Murota H
    Mod Rheumatol; 2010 Apr; 20(2):123-9. PubMed ID: 20054701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus.
    Ruzicka T; Faes J; Bergner T; Peter RU; Braun-Falco O
    J Am Acad Dermatol; 1991 Sep; 25(3):557-60. PubMed ID: 1918494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annular erythema of Sjögren's syndrome treated successfully with low-dose cyclosporine.
    Nobeyama Y; Matsuzaki H; Nakagawa H
    J Dermatol; 2014 May; 41(5):463-4. PubMed ID: 24801928
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
    Ponge T; Mussini JM; Ponge A; Forgeau Y; Barrier J; Cottin S; Grolleau JY
    Rev Neurol (Paris); 1987; 143(2):147-8. PubMed ID: 3602794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astasia-abasia revealing a primary Sjögren's syndrome.
    Lafforgue P; Toussirot E; Billé F; Acquaviva PC
    Clin Rheumatol; 1993 Jun; 12(2):261-4. PubMed ID: 8358991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    Ward JM; Hess JN; Davis LS
    J Rheumatol; 2020 Feb; 47(2):298-299. PubMed ID: 32007943
    [No Abstract]   [Full Text] [Related]  

  • 19. RAPID3 correlates with ESSPRI and other patient-reported outcomes in patients with primary Sjögren's syndrome.
    Pertovaara M; Korpela M
    Clin Exp Rheumatol; 2017; 35(4):718. PubMed ID: 28516885
    [No Abstract]   [Full Text] [Related]  

  • 20. Remitting seronegative symmetrical synovitis with pitting edema and primary Sjögren's syndrome.
    Fietta P; Manganelli P
    Clin Exp Rheumatol; 2000; 18(2):269-70. PubMed ID: 10812512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.